Voluntary Announcement - Receiving the Certificate of Registration of Proprietary Chinese Medicine
Filed with HKEX · Stock code 3613 · · 2 pages · English
Summary by 6ix AI
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. has announced the receipt of a Certificate of Registration for its proprietary Chinese medicine, Dingzhi Wan, allowing it to be sold in Hong Kong. The announcement details the medicine's functions, indications, and the company's investment in its research and development. The company expects that obtaining the certificate will aid in expanding its product lines and market presence, although it does not anticipate a significant immediate impact on its operations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. on 6ix
Earlier from Beijing Tong Ren Tang Chinese Medicine
- Monthly Return for Equity Issuer on Movements in Securities
- Interim Report 2026
- Beijing Tong Ren Tang Sparks New Momentum in the Inheritance of TCM through Student Ambassador Programme
- Tong Ren Tang Chinese Medicine Announces 2024 Interim Results
- Financial Information Announcement of Tong Ren Tang Technologies For The First Quarter of 2021
Follow Beijing Tong Ren Tang Chinese Medicine into a list and get an email when it puts out news.
Follow Beijing Tong Ren Tang Chinese Medicine